市场快照

Study Period: | 2018 - 2026 |
Base Year: | 2021 |
CAGR: | 8.4 % |
![]() |
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
透视设备市场的主要驱动力是微创手术需求的增长、老年人口的增长、慢性病的流行以及透视在疼痛管理中的使用增加。
医学成像在住院管理过程的各个阶段都有应用,例如诊断、分期、治疗实施及其后续行动。成像的主要作用一直是诊断,但对于由微创手术驱动的介入诊断和治疗用途,它正在缓慢增加。透视呈现实时运动图像,用于软组织和硬组织状况的诊断评估。它是许多介入医疗程序不可或缺的工具。预计透视市场将出现显着增长,包括使用的设备在内的高精度微创手术数量将增加,从而为患者和外科医生提供更好的支持。2017 年 12 月,Hologic Inc. 在芝加哥举行的 2017 年亚太放射学会 (RSNA) 年会上推出了 Fluoroscan InSight FD Mini C-Arm 四肢成像系统。该地区产品和新产品的推出也推动了市场的发展。然而,与辐射相关的副作用预计将阻碍预测期内的市场增长。
Scope of the report
As per the scope of the report, fluoroscopy refers to an imaging technique that uses X-rays to produce real-time images of internal organs. Unlike X-ray images, which are fixed still images on film, the fluoroscopy produces live moving pictures of internal organs, which can be viewed by the naked eye on a digital monitor. This report is segmented by Device Type, Application and by Geography.
By Device Type | ||||
Fixed Fluoroscopes | ||||
|
By Application | |
Orthopedic | |
Cardiovascular | |
Pain Management and Trauma | |
Neurology | |
Gastrointestinal | |
Urology | |
General Surgery | |
Other Applications |
Geography | ||||||||
|
主要市场趋势
在预测期内,正在申请的心血管领域预计将占据最大的市场份额
心血管手术需要广泛的透视引导来导航血管内导管。透视提供了出色的空间和时间分辨率,限制了对患者和工作人员的电离辐射暴露,以及较差的软组织表征。在心导管插入术的过程中,透视用于帮助医疗保健提供者查看通过冠状动脉的血液流动,以检查动脉阻塞。因此,该地区心血管疾病患病率的上升是推动市场增长的主要因素。根据澳大利亚统计局 (ABS) 2017-18 年全国健康调查的自我报告数据,估计有 120 万澳大利亚 18 岁及以上的成年人患有一种或多种与心脏或血管疾病相关的疾病,包括 2017-2018 年的中风。因此,由于心脏病发病率的上升以及与透视相关的益处,预计市场将在预测期内增长。

To understand key trends, Download Sample Report
竞争格局
亚太荧光镜市场与几个主要参与者竞争适度。实施的一些战略包括协议、协作模式、业务扩展和产品开发。一些主要参与者 Merck KGaA、Thermo Fisher Scientific、GE Healthcare、Sovicell GMBH、Absorption Systems、Eurofins Scientific、ADMEcell, Inc.
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Growing Geriatric Population and Prevalence of Chronic Diseases
-
4.2.2 Rising Demand for Minimally-invasive Surgeries
-
4.2.3 Increasing Use of Fluoroscopy in Pain Management
-
-
4.3 Market Restraints
-
4.3.1 Side Effects and Radiation Exposure
-
4.3.2 Rising Adoption of Refurbished Systems
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Device Type
-
5.1.1 Fixed Fluoroscopes
-
5.1.2 Mobile Fluoroscopes
-
5.1.2.1 Full-size Fluoroscopes
-
5.1.2.2 Mini Fluoroscopes
-
-
-
5.2 By Application
-
5.2.1 Orthopedic
-
5.2.2 Cardiovascular
-
5.2.3 Pain Management and Trauma
-
5.2.4 Neurology
-
5.2.5 Gastrointestinal
-
5.2.6 Urology
-
5.2.7 General Surgery
-
5.2.8 Other Applications
-
-
5.3 Geography
-
5.3.1 Asia-Pacific
-
5.3.1.1 China
-
5.3.1.2 Japan
-
5.3.1.3 India
-
5.3.1.4 Australia
-
5.3.1.5 South Korea
-
5.3.1.6 Rest of Asia-Pacific
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Canon Medical Systems Corporation
-
6.1.2 GE Healthcare (GE Company)
-
6.1.3 Hitachi Medical Systems
-
6.1.4 Siemens Healthineers
-
6.1.5 Hologic Inc.
-
6.1.6 Orthoscan Inc.
-
6.1.7 Shimadzu Medical
-
6.1.8 Koninklijke Philips NV
-
6.1.9 Carestream Health
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Asia-Pacific Fluoroscopy Market market is studied from 2018 - 2026.
What is the growth rate of Asia-Pacific Fluoroscopy Market?
The Asia-Pacific Fluoroscopy Market is growing at a CAGR of 8.4% over the next 5 years.
Who are the key players in Asia-Pacific Fluoroscopy Market?
Canon Medical Systems Corporation, GE Healthcare (GE Company), Hitachi Medical Systems, Siemens Healthineers, Hologic Inc. are the major companies operating in Asia-Pacific Fluoroscopy Market.